Literature DB >> 16389456

Development of dopaminergic neurons in the mammalian brain.

N Prakash1, W Wurst.   

Abstract

Dopaminergic neurons in the mammalian brain have received substantial attention in the past given their fundamental role in several body functions and behaviours. The largest dopaminergic population is found in two nuclei of the ventral midbrain. Cells of the substantia nigra pars compacta are involved in the control of voluntary movements and postural reflexes, and their degeneration in the adult brain leads to Parkinson's disease. Cells of the ventral tegmental area modulate rewarding and cognitive behaviours, and their dysfunction is involved in the pathogenesis of addictive disorders and schizophrenia. Because of their clinical relevance, the embryonic development and maintenance of the midbrain dopaminergic cell groups in the adult have been intensively studied in recent years. In the present review, we provide an overview of the mechanisms and factors involved in the development of dopaminergic neurons in the mammalian brain, with a special emphasis on the midbrain dopaminergic population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16389456     DOI: 10.1007/s00018-005-5387-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  64 in total

1.  Dopaminergic neuronal conversion from adult rat skeletal muscle-derived stem cells in vitro.

Authors:  Jian Yang; Xuan Wang; Yue Wang; Zi-Xuan Guo; Ding-Zhen Luo; Jun Jia; Xiao-Min Wang
Journal:  Neurochem Res       Date:  2012-06-22       Impact factor: 3.996

2.  Interleukin-1beta-induced brain injury and neurobehavioral dysfunctions in juvenile rats can be attenuated by alpha-phenyl-n-tert-butyl-nitrone.

Authors:  L W Fan; L T Tien; B Zheng; Y Pang; P G Rhodes; Z Cai
Journal:  Neuroscience       Date:  2010-03-24       Impact factor: 3.590

Review 3.  Potential programming of dopaminergic circuits by early life stress.

Authors:  Ana-João Rodrigues; Pedro Leão; Miguel Carvalho; Osborne F X Almeida; Nuno Sousa
Journal:  Psychopharmacology (Berl)       Date:  2010-11-19       Impact factor: 4.530

4.  Study of a fetal brain affected by a severe form of tyrosine hydroxylase deficiency, a rare cause of early parkinsonism.

Authors:  Alba Tristán-Noguero; Héctor Díez; Cristina Jou; Mercè Pineda; Aida Ormazábal; Aurora Sánchez; Rafael Artuch; Àngels Garcia-Cazorla
Journal:  Metab Brain Dis       Date:  2015-12-21       Impact factor: 3.584

5.  Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons.

Authors:  Sarah A McClymont; Paul W Hook; Alexandra I Soto; Xylena Reed; William D Law; Samuel J Kerans; Eric L Waite; Nicole J Briceno; Joey F Thole; Michael G Heckman; Nancy N Diehl; Zbigniew K Wszolek; Cedric D Moore; Heng Zhu; Jennifer A Akiyama; Diane E Dickel; Axel Visel; Len A Pennacchio; Owen A Ross; Michael A Beer; Andrew S McCallion
Journal:  Am J Hum Genet       Date:  2018-11-29       Impact factor: 11.025

Review 6.  Genetic networks controlling the development of midbrain dopaminergic neurons.

Authors:  Nilima Prakash; Wolfgang Wurst
Journal:  J Physiol       Date:  2006-07-06       Impact factor: 5.182

7.  Expression of transgenes in midbrain dopamine neurons using the tyrosine hydroxylase promoter.

Authors:  M S Oh; S J Hong; Y Huh; K-S Kim
Journal:  Gene Ther       Date:  2008-09-18       Impact factor: 5.250

8.  Nucleotides affect neurogenesis and dopaminergic differentiation of mouse fetal midbrain-derived neural precursor cells.

Authors:  Jasmin Delic; Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2011-01-06       Impact factor: 3.765

Review 9.  Desire, disease, and the origins of the dopaminergic system.

Authors:  Roy V Sillitoe; Michael W Vogel
Journal:  Schizophr Bull       Date:  2008-02-17       Impact factor: 9.306

10.  Ontogenetic expression of dopamine-related transcription factors and tyrosine hydroxylase in prenatally stressed rats.

Authors:  Maria R Katunar; Trinidad Saez; Alicia Brusco; Marta C Antonelli
Journal:  Neurotox Res       Date:  2009-11-20       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.